22.89
Schlusskurs vom Vortag:
$22.65
Offen:
$22.76
24-Stunden-Volumen:
907.75K
Relative Volume:
1.17
Marktkapitalisierung:
$2.83B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
190.75
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
-1.51%
1M Leistung:
-8.51%
6M Leistung:
+4.66%
1J Leistung:
+31.02%
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PRVA
Privia Health Group Inc
|
22.89 | 2.83B | 1.80B | 15.62M | 118.36M | 0.12 |
![]()
VEEV
Veeva Systems Inc
|
284.58 | 46.30B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
72.00 | 11.59B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
55.96 | 10.91B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
101.08 | 9.61B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
38.74 | 7.05B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Eingeleitet | Needham | Buy |
2024-12-16 | Eingeleitet | Macquarie | Outperform |
2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
2024-04-22 | Eingeleitet | Citigroup | Buy |
2024-03-06 | Eingeleitet | Barclays | Equal Weight |
2024-02-26 | Fortgesetzt | Jefferies | Buy |
2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
2023-04-12 | Eingeleitet | Stephens | Overweight |
2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-02-03 | Eingeleitet | Goldman | Buy |
2022-12-09 | Eingeleitet | Stifel | Buy |
2022-12-08 | Eingeleitet | UBS | Buy |
2022-09-07 | Fortgesetzt | Truist | Buy |
2022-05-03 | Eingeleitet | BofA Securities | Buy |
2022-04-28 | Eingeleitet | BTIG Research | Buy |
2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
2022-03-30 | Eingeleitet | Guggenheim | Buy |
2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
2022-01-03 | Eingeleitet | Jefferies | Buy |
2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
2021-09-10 | Eingeleitet | Cowen | Market Perform |
2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
2021-05-24 | Eingeleitet | JP Morgan | Overweight |
2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
2021-05-24 | Eingeleitet | Truist | Buy |
2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health stock named TD Cowen’s ’Best Smidcap Idea’ By Investing.com - Investing.com UK
Park Avenue Securities LLC Has $342,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by GAMMA Investing LLC - Defense World
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com Australia
Privia Health’s SWOT analysis: capital-efficient model drives stock growth By Investing.com - Investing.com Canada
Rhumbline Advisers Increases Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance - MSN
California State Teachers Retirement System Sells 879 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts - Defense World
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution - MSN
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution Offset Revenue Miss - FinancialContent
How To Trade (PRVA) - news.stocktradersdaily.com
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About - Yahoo Finance
Two Sigma Advisers LP Buys Shares of 48,100 Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $32.00 at JPMorgan Chase & Co. - Defense World
Ziegler Advises Integrated Medical Services On Partnership with Privia Health Group - Yahoo Finance
PRVA Stock Target Raised by JP Morgan Analyst | PRVA Stock News - GuruFocus
JPMorgan Increases Price Target for Privia Health (PRVA) to $32 - GuruFocus
JPMorgan Increases Price Target for Privia Health (PRVA) to $32 | PRVA Stock News - GuruFocus
Privia Health Group (NASDAQ:PRVA) Given New $24.00 Price Target at Barclays - Defense World
11 Analysts Have This To Say About Privia Health Gr - Benzinga
Privia Health Gr (PRVA) Sees Price Target Boost by Barclays | PRVA Stock News - GuruFocus
Barclays Adjusts Privia Health (PRVA) Price Target Post Q1 | PRV - GuruFocus
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Ameriprise Financial Inc. - Defense World
(PRVA) Long Term Investment Analysis - news.stocktradersdaily.com
Cetera Investment Advisers Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group Approves Key Proposals at Meeting - TipRanks
Bank of America Corp DE Has $19.98 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
3 Healthcare Stocks with Mounting Challenges - Yahoo Finance
Investing in Smarter Healthcare: The New Era of AI-Driven Medicine - The Globe and Mail
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks - Yahoo Finance
Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings - Yahoo Finance
Top Executives Cash In on Privia Health Group Stock - TipRanks
How the (PRVA) price action is used to our Advantage - news.stocktradersdaily.com
The Manufacturers Life Insurance Company Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Privia Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook - TipRanks
Has Privia Health Group, Inc.'s (NASDAQ:PRVA) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Tower Research Capital LLC TRC Sells 799 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Truist Securities Adjusts Price Target on Privia Health Group to $30 From $28, Maintains Buy Rating - marketscreener.com
Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance - Investing.com
Privia Health: Q1 Earnings Snapshot - New Haven Register
Privia Health Group Inc (PRVA) Q1 2025 Earnings Call Highlights: Strong Growth and Strategic ... By GuruFocus - Investing.com Canada
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):